Generex Biotechnology Corporation
GNBTQ
OTC PK
| 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | 04/30/2020 | |
|---|---|---|---|---|---|
| Net Income | 9.22M | -24.08M | -10.73M | -11.67M | -5.63M |
| Total Depreciation and Amortization | 280.40K | 282.00K | 278.30K | 322.80K | 228.70K |
| Total Amortization of Deferred Charges | 635.60K | 166.20K | 174.00K | 619.80K | 840.00K |
| Total Other Non-Cash Items | -16.22M | 15.55M | -2.92M | 6.09M | 1.16M |
| Change in Net Operating Assets | 6.66M | 7.10M | 11.86M | 4.01M | 2.53M |
| Cash from Operations | 576.70K | -980.20K | -1.34M | -634.20K | -871.90K |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 2.05M | -- | -- | 245.00K | 1.02M |
| Total Debt Repaid | -2.24M | -67.50K | -60.00K | 0.00 | 0.00 |
| Issuance of Common Stock | 691.70K | 978.30K | 2.22M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | -170.40K | -- | -- | -- |
| Cash from Financing | 502.30K | 740.40K | 2.16M | 245.00K | 1.02M |
| Foreign Exchange rate Adjustments | -- | 2.20K | -2.20K | -11.90K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.08M | -237.50K | 818.10K | -401.20K | 147.60K |
